Search

everythinglearnresearchcommunity

for

Search:↓

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Topical treatments led to hair regrowth in a man with linear morphea.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

A group has developed therapies that show promise for treating cancer and various other conditions.